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Adding omega-3 fatty acids to a protein-based supplement during pre season 1 
training results in reduced muscle soreness and the better maintenance of 2 
explosive power in professional Rugby Union players. 3 
 4 
Abstract 5 
Evidence suggests that omega-3 fatty acid supplementation could reduce muscle 6 
soreness and maintain muscle function following eccentric exercise-induced muscle 7 
damage. The aim of this applied field study was to investigate the effectiveness of 8 
consuming a protein-based supplement containing 1546 mg of omega-3 PUFA (551 9 
mg eicosapentaenoic acid (EPA) and 551 mg docosahexaenoic acid (DHA)) twice 10 
daily (FO) compared to a protein-based placebo (P) on muscle soreness, 11 
countermovement jump (CMJ) performance and psychological well-being in 20 12 
professional Rugby Union players during 5 weeks of pre-season training. Players 13 
completed a 5-point likert soreness scale with 5 indicating “no soreness” and a 14 
questionnaire assessing fatigue, sleep, stress and mood each morning of training, plus 15 
they performed countermovement jump (CMJ) tests once or twice per week. Data 16 
were analysed using magnitude-based inferential statistics and are presented as 17 
percent beneficial/trivial/harmful. On day 35, there was a likely (% 18 
beneficial/trivial/harmful: 94/5/1) moderate (0.75, standardized mean difference 19 
(SMD)) beneficial effect of FO vs. P on the change in lower body muscle soreness 20 
compared with day 0 (FO: -3.8±21.7%; P: -19.4±11.2%). There was a likely (92/7/0) 21 
moderate (SMD: 0.60) beneficial effect of FO vs. P on CMJ performance (change 22 
from baseline to day 35, FO: +4.6±5.9%; P: -3.4±8.6%). From day 20, a moderate 23 
beneficial effect of FO on fatigue was observed. In terms of practical relevance, the 24 
moderate beneficial effect of adding fish oil to a protein-based supplement on muscle 25 
  
soreness translated into the better maintenance of explosive power in elite Rugby 26 
Union players during pre-season training.  27 
 28 
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 30 
Introduction 31 
Athletes involved in contact sports such as Rugby Union are regularly exposed to 32 
muscle damage during both training and match play (Naughton, Miller, & Slater, 33 
2017). The physiological demands of Rugby Union result in an acute inflammatory 34 
response and elevations in blood creatine kinase and myoglobin concentrations during 35 
acute recovery. Such perturbations are indicative of structural damage to the muscle 36 
and/or extracellular matrix (Takarada, 2003; Cunniffe et al., 2010). The level of 37 
structural damage to the muscle fibres during Rugby depends, in part, on the number 38 
of tackles experienced, which causes muscle trauma (Takarada, 2003; Cunniffe et al., 39 
2010). Further, repetitive sprints with rapid decelerations result in eccentric muscle 40 
contractions which also contribute to muscle damage (Naughton, Miller, & Slater, 41 
2017). This damage is initiated by overstretching of the sarcomere, and leads to 42 
membrane disruption of the sarcolemma and t-tubules, excitation-contraction 43 
coupling dysfunction, entry of calcium ions into the sarcolemma and ultimately loss 44 
of muscle strength (Takarada, 2003; Peake, Neubauer, Della Gatta, & Nosaka, 2017). 45 
While the exact aetiology of muscle damage and its associations with soreness remain 46 
unresolved (Close, Ashton, Cable, Doran, & MacLaren, 2004), there is evidence that 47 
muscle soreness is linked to inflammation, connective tissue damage, muscle damage, 48 
or is caused by structural damage to the extracellular matrix during exercise (Lewis, 49 
Ruby, & Bush-Joseph, 2012; Peake et al., 2017). 50 
  
 51 
The rugby pre-season period is characterised by intensive daily training sessions with 52 
an emphasis on speed, strength, endurance and contact. Therefore, coaches 53 
progressively overload training to transition players from the off-season to the 54 
competitive season. Despite the focus of pre-season being on training adaptation, and 55 
the notion that interfering with the recovery process may blunt the adaptive response 56 
to exercise (Markworth, Maddipati, & Cameron-Smith, 2016), optimising recovery 57 
during this period is pertinent for players to maintain the intensities required for each 58 
training session. Pre-season also is a period during which nutritional strategies for the 59 
competitive season can be practiced and evaluated. In theory, attenuating muscle 60 
damage with nutritional interventions during this period could facilitate players to 61 
better maintain performance, potentially via psychological and physiological 62 
mechanisms (McLean, Coutts, Kelly, McGuigan, & Cormack, 2010; Tavares, Smith, 63 
& Driller, 2017b).  64 
 65 
The most common nutritional strategy investigated for recovery from muscle 66 
damaging exercise is protein. Amino acid ingestion facilitates muscle protein turnover 67 
during recovery (Tipton, Ferrando, Phillips, Doyle and Wolfe, 1999), synthesizing 68 
new muscle proteins and repairing old damaged proteins. In theory, promoting the 69 
repair of damaged proteins reduces the severity of exercise-induced muscle damage 70 
and accelerates recovery. However, since mixed results have been reported for protein 71 
ingestion and muscle recovery from damaging exercise (Pasiakos, Lieberman, & 72 
McLellan, 2014), alterative nutritional interventions warrant investigation.  73 
 74 
  
Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation also has received 75 
attention for its potential to aid recovery (Gray, Chappell, Jenkinson, Thies, & Gray, 76 
2014; Lenn et al., 2002; Tartibian, Maleki, & Abbasi, 2010). Fish oils contain the n-3 77 
PUFA’s, 20:5n3 (eicosapentaenoic acid, EPA) and 22:6n3 (docosahexaenoic acid, 78 
DHA). The incorporation of EPA and DHA into cellular membranes exerts anti-79 
inflammatory properties by initiating a reduction in the pro-inflammatory hormones 80 
(Calder, 2015; Erikson, 1996). In addition, n-3 PUFA ingestion reduces oxidative 81 
stress, evidenced by a reduction in the expression of plasma thiobarbituric acid and 82 
H2O2 – induced lymphocyte DNA damage following exercise (Gray et al., 2014). 83 
Hence, it has been suggested that omega-3 PUFA ingestion can act as a free radical 84 
scavenger (Barbosa et al., 2003), which can modulate the production of prostaglandin 85 
E2, whereby there is a decrease in PGE-2 production and an increase in PGE-3 86 
(Calder, 2006). Dietary n-3 PUFA also are essential components of nerve endings and 87 
the myelin sheath of neurons of the nervous system (Pu et al., 2013; Laye, Nadjar, 88 
Joffre, & Bazinet, 2018). Specifically, DHA is readily incorporated into the neuronal 89 
membrane where it appears to exert its biological action. For example, 21 days of n-3 90 
PUFA supplementation during training was shown to enhance neuromuscular 91 
development in athletes (Lewis, Radonic, Wolever, & Wells, 2015). Hence, there is 92 
scientific rationale to link n-3 PUFA ingestion with a reduced inflammatory response 93 
to exercise and improved neuromuscular function (Lewis et al., 2015).  94 
 95 
The majority of previous studies that investigated the impact of n-3 PUFA 96 
supplementation on recovery from exercise-induced muscle damage were conducted 97 
within a controlled laboratory setting, whereby muscle damage was initiated by 98 
protocols (i.e., knee extension/flexion on isokinetic dynamometer, downhill running) 99 
  
that do not necessarily reflect the typical movement patterns of elite athletes (Corder, 100 
Newsham, McDaniel, Ezekiel, & Weiss, 2016; Gray et al., 2014; Jouris, McDaniel, & 101 
Weiss, 2011; Lembke, Capodice, Hebert, & Swenson, 2014; Lenn et al., 2002; 102 
McGlory et al., 2016). For example, Jouris et al (2011) reported an attenuation of 103 
muscle soreness with the ingestion of 3 g/day of n-3 PUFA over a 7 day 104 
supplementation period following an eccentric bicep curl exercise protocol (Jouris et 105 
al., 2011). The beneficial role of n-3 PUFA ingestion was primarily attributed to an 106 
anti-inflammatory response. However, the lack of a blinded placebo condition means 107 
that a “placebo effect” cannot be eliminated as a possible reason for the findings. In 108 
contrast, two experimental studies (Gray et al. 2014; Lenn et al. 2002) reported no 109 
changes in blood CK concentrations, performance or muscle soreness with fish oil 110 
supplementation following eccentric based exercise. However, given that the change 111 
in muscle function following exercise was negligible, Gray et al. (2014) acknowledge 112 
the exercise protocol utilized exerted only mild muscle damage and may explain why 113 
no differences were detected. Given these equivocal findings, there is scope to 114 
investigate the influence of n-3 PUFA ingestion on exercise recovery using a training 115 
model of muscle damage that simulates the functional movements of elite athletes 116 
within an applied field setting (Cockburn, Bell, & Stevenson, 2013).  117 
 118 
Therefore, the primary aim of the present study was to assess the impact of a twice 119 
daily supplement of n-3 PUFA combined with protein on muscle recovery in 120 
professional Rugby Union players during a 5 week training camp. We hypothesised 121 
that twice daily supplementation with 1546mg omega-3 PUFA (551 mg EPA and 551 122 
mg DHA) would reduce the perception of muscle soreness, attenuate the decline in 123 
  
countermovement (CMJ) jump performance and improve general well-being in elite 124 
Rugby Union players during pre-season training.  125 
 126 
Methods 127 
This double-blind, parallel designed, intervention study received ethics approval from 128 
the University of Otago, Human Health Ethics Committee. A verbal and written 129 
explanation of study procedures was provided to all participants, before providing 130 
written informed consent to participate. Thirty-three professional Rugby Union 131 
players volunteered to participate in the study. Participants were assigned to either a 132 
fish oil (FO) or placebo (P) supplement group, stratified by playing position and body 133 
composition goals (e.g. as part of pre-season players are placed into one of three 134 
groups based on their current skinfold measures and their individual optimal 135 
skinfolds. These groups are 1) gain muscle mass, 2) maintain current body 136 
composition, 3) lose body fat). While 16 players were assigned to FO and 17 to P, 137 
only 9 in FO and 11 in P completed the study. The mean age of participants was 22 138 
years and 7 months (SD: 2 years 11 months; range: 18 years 11 months - 27 years 11 139 
months). Two participants dropped out of the study due to gastrointestinal illness and 140 
7 to training related injury. Six players did not complete all data collection.  141 
 142 
Pre-season training schedule. All players performed 5 weeks of pre-season training 143 
as scheduled by team coaching staff. Training took place 5 days per week from 8am 144 
to 5pm, with sessions including strength and conditioning, match skills/simulated 145 
match play and flexibility on Monday, Tuesday, Thursday and Friday. Wednesday 146 
sessions were a recovery day, consisting of light training and meetings. Weekly 147 
training distances covered were 19.3±3.8 km (FO 17.6±7.0 km P 21.0±6.5 km). 148 
  
During weeks 4-5, players travelled to Australia and completed a pre-season rugby 149 
match and a rugby 10s tournament.  150 
 151 
Resistance training comprised of a strength intensification phase where all players 152 
were required to perform the same exercises, including sets and repetitions. The load 153 
for each repetition was based on individual 1RMs. The on-field training load was 154 
monitored via GPS (Statsports viper system, Statsports Group Ltd, N. Ireland). On-155 
field training load was measured as fast running distance (FAST = velocity 4-7 m/s), 156 
sprint distance (SPRINT = velocity > 7 m/s) and High Metabolic Load Distance 157 
(HMLD = W/kg > 25.5). Equations developed by di Prampero et al., (2005) and 158 
Osgnach, Poser, Bernardini, Rinaldo, & di Prampero, (2010) enabled the calculation 159 
of metabolic power output (HMLD), which our research (Smith, Tarrant and 160 
McIntosh, In press) suggests more accurately accounts for the energetic costs of 161 
acceleration and deceleration that occur during the intermittent and intensive running 162 
that is common in rugby (Gaudino et al., 2013; Kempton, Sirotic, Rampinini, & 163 
Coutts, 2015). 164 
 165 
Dietary supplementation. Participants consumed two, 200 mL protein-based drinks 166 
daily for 5 weeks. The intervention group (FO) consumed drinks that contained 167 
multiple nutrients including 1546 mg of omega-3 PUFA (551 mg EPA and 551 mg 168 
DHA), whereas the placebo (P) group consumed drinks matched for protein 169 
(15.0g/200mL), carbohydrate (14.5g/200mL) and fat content (8.4g/200mL), but 170 
without omega 3 PUFA (Smartfish, Oslo, Norway). All drinks were served in 171 
identical white packages. While training in New Zealand, participants consumed one 172 
test drink after morning training and the other following afternoon training. These 173 
  
drinks were consumed alongside a protein shake containing an additional 15g of whey 174 
protein (BSc, Whey Protein Powder, Body Science, Auckland, New Zealand). As 175 
players left training on Friday they were provided with four additional drinks and 176 
asked to consume one in the morning and one in the afternoon with meals on Saturday 177 
and Sunday. When in Australia (days 26-33) coaching staff provided players with 178 
drinks twice per day. All players were aware of best nutrition practices during flights, 179 
particularly regarding the importance of hydration. Accordingly, there was no 180 
difference in hydration status assessed via Urine Specific Gravity (Atago Ltd, Tokyo, 181 
Japan) from the first void of day 1 (FO: 1.024±0.005; P: 1.025±0.004) to the first void 182 
of day 35 (FO: 1.021± 0.010, P: 1.022±0.004).   183 
 184 
Breakfast, lunch and all snacks were consumed at training, i.e. Monday to Friday each 185 
week and all meals whilst in Australia were provided by the team nutritionist.  186 
 187 
Data collection  188 
Ear lobe blood samples were collected at baseline, day 19 and day 35, following at 189 
least 48 hours without strenuous exercise and were later analysed for percent fatty 190 
acid composition. All blood samples were collected upon arrival at training prior to 191 
breakfast (7:30-8:00 am). The ear lobe was cleaned with an alcohol swab then 192 
punctured by a lancet (Becton, Dickinson contact activated lancet, Auckland, New 193 
Zealand). Blood was dispensed into eppendorf tubes containing EDTA and stored at -194 
80oC. At these timepoints, players were asked to record their weekly dietary fish 195 
consumption. Additional measurements were collected during the pre-season training 196 
period, including CMJ peak force, perceived feelings of muscle soreness, a McLean 197 
questionnaire on fatigue, sleep, stress and mood (McLean et al., 2010), skinfold 198 
  
assessments and strength (table 1). On day 35, participants were asked to predict 199 
whether they had been assigned to FO or P conditions.  200 
 201 
Skinfold measurements. A level 1 trained and accredited International Society for the 202 
Advancement of Kinanthropometry (ISAK) anthropometrist performed skinfold 203 
measurements from eight sites (triceps, subscapular, biceps, iliac crest, supraspinale, 204 
abdominal, thigh, calf) on the right hand side of the body using body fat calipers 205 
(Holtain Ltd., Crosswell, United Kingdom) and tape measures (Lufkin Executive 206 
Thinline, W606PM). Skinfold measurements were collected at baseline and on the 207 
final day of the study and the average technical error of measurement (TEM) was 208 
0.9%. 209 
 210 
Countermovement jump performance. To measure neuromuscular fatigue, peak force 211 
(N) was measured using a CMJ test. All vertical jumps were performed between 212 
08:00 and 10:00 AM following breakfast, at baseline, days 5, 12, 16, 19, 22 and on 213 
day 35. Participants completed a standardized warm-up of dynamic stretches and 214 
bodyweight movements. Participants performed three CMJ with a brief rest between 215 
each jump on two force plates one under each foot (PASCO PS 2142, Roseville, CA, 216 
USA) to enable the measurement of peak force at a sample rate of 500Hz. The total 217 
ground reaction force was calculated as the sum of the left and right force plate 218 
measures. Participants began each CMJ standing on the force plates with their knees 219 
fully extended and hands on their hips. Participants descended to a self-selected depth 220 
and jumped as high and quickly as possible. The best attempt, determined by peak 221 
force, was used for data analysis. CMJ is regularly performed, therefore all 222 
participants were familiar with the protocols. Force platform data were analysed using 223 
  
Pasco Capstone v1.4.0 software (PASCO, Roseville, California, USA). Our 224 
unpublished data from 18 elite Rugby Union players demonstrated an acceptable level 225 
of test-retest reliability (ICC: 0.89; CV: 4.6%). 226 
 227 
Subjective muscle soreness and wellness questionnaire. This questionnaire has been 228 
previously utilised to reflect changes in training load amongst Rugby League players 229 
(McLean et al., 2010; Tavares, Healey, Smith, & Driller, 2017). In this study, the 230 
questionnaires were used to determine subjective scores for muscle soreness, fatigue, 231 
mood, sleep and stress (McLean et al., 2010). Participants rated responses on a 5 point 232 
likert scale (1-5). A higher score represented a positive response. All players were 233 
familiar with this questionnaire as it formed part of the team’s habitual monitoring 234 
procedure. Upper and lower body muscle soreness scores were rated using a diagram 235 
of a person with muscle groups divided into six compartments for both sides of the 236 
body (quadriceps, groin, calf, hamstrings, gluteus and upper body). Each muscle 237 
group was rated from 1-5 with 1 being “very sore” and 5 being “feeling great”. 238 
Therefore the maximum score for the lower body was 50 and upper body was 10. All 239 
questionnaires were completed prior to training.  240 
 241 
Blood treatment and analysis. Plasma, erythrocyte, and buccal cell lipids were 242 
extracted using the method of Bligh and Dyer (Bligh & Dyer, 1959). Samples were 243 
then analysed by Gas Chromatograph with flame ionization detection (HP-5890 244 
Series, Hewitt-Packard, Wilmington, USA), as previously described (Dodds, McCoy, 245 
Rea, & Kennish, 2005). In brief, samples were thawed, dried and then extracted with 246 
chloroform and methanol at 200oC and 13.8 MPa, before further drying, rinsing and 247 
evaporation with nitrogen. The recovered lipids were reconstituted and hydrolyzed. 248 
  
One mL of distilled water and 2 mL of hexane were mixed with the solution. The 249 
organic portion was removed and an internal standard added, which allows for the 250 
calculation of absolute values for % omega 3 PUFA concentrations.  251 
 252 
Data handling and statistical analysis.  253 
All data were analysed using magnitude-based inferential statistics to determine 254 
inferences about the true effects of the intervention on CMJ, strength and the various 255 
subjective measures (Hopkins, 2007; Hopkins, 2018). This statistical approach allows 256 
for quantitative (trivial, small, moderate, large or very large) descriptions of the 257 
magnitude of difference between trials and establishes the likelihood of the 258 
experimental condition (i.e. FO) having a beneficial, trivial or harmful effect on the 259 
outcome of interest. Standardised Mean Differences (SMD) were calculated as the 260 
difference between the means divided by the pooled standard deviation. The 261 
following quantitative criteria for the SMD was used to explain the practical 262 
significance of the findings: trivial <0.20; small 0.20-0.59; moderate 0.60-1.19; large 263 
1.20-1.99; very large 2.0-3.90; and almost perfect >4.00. Quantitative chances of real 264 
differences in variables between groups were assessed qualitatively as <1%, almost 265 
certainly not; 1% to 5%, very unlikely; 5% to 25%, probably not; 25% to 75%, 266 
possibly; 75% to 97.5%, likely; 97.5% to 99%, very likely; >99%, most likely. If the 267 
chances of a variable having beneficial and harmful differences which were >5%, the 268 
true effect was deemed to be unclear (Hopkins, 2010). Quantitative data are presented 269 
as percent beneficial/trivial/harmful. Data are provided as mean ± standard deviation 270 
(SD) and standardized mean differences (SMD), unless otherwise stated.   271 
 272 
 273 
  
Results 274 
Training 275 
The average weekly distance covered in the intensive metrics was FAST: FO 2.5±0.9 276 
km, P 2.7±0.7 km; HMLD: FO 2.3±0.8 km P 2.5±0.7 km; SPRINT: FO 177±156 m P 277 
166±170 m. There were small but unclear differences between FO and P for both 278 
FAST (SMD = 0.36, 81/0/19) and HMLD (SMD = 0.28, 76/1/22), while trivial 279 
differences between FO and P for SPRINT (SMD = 0.07, 43/1/56).   280 
 281 
Compliance and blood fatty acid concentrations 282 
Compliance to consuming two drinks per day ranged from 79-100% while in New 283 
Zealand, with twelve players consuming 100% of their training drinks. Coaching staff 284 
reported all drinks were consumed in Australia. At baseline % omega-3 PUFA 285 
concentrations were 1.12±0.89 % and 1.41± 1.01 % for FO and P respectively, 286 
changing to 3.81±5.66 % and 1.30±1.13 % after 5 weeks for FO and P respectively 287 
(figure 1). Accounting for baseline values, there was a very large likely beneficial 288 
effect of FO on omega-3 PUFA concentrations compared to PLA (SMD 2.84, 87/6/8).  289 
 290 
Dietary intakes and randomization 291 
Dietary fish consumption ranged from 0 to 3 servings per week at both the mid- (FO: 292 
1.3 ± 0.8 servings per week and P: 0.9 ± 1.3 servings per week) and final (FO: 293 
1.83±1.00 servings per week and P: 1.80±1.03 servings per week) time point.  294 
Twenty-seven percent of participants in P correctly stated that they were assigned to 295 
the placebo, whereas a further 27% incorrectly believed they were assigned to the FO 296 
condition and remaining participants were unsure. 297 
 298 
  
Anthropometrics  299 
In FO, body mass increased from 106.9±8.3 kg to 107.1±8.1 kg whereas in P, body 300 
mass increased from 106.7±16.5 kg to 107.3±16.6kg (SMD -0.03, trivial; 100% most 301 
likely trivial effect). In FO, the sum of eight skinfolds was 70.8±14.4 mm at baseline 302 
and 67.5±15.5 mm post intervention, whereas P was 74.4±17.2 mm at baseline 303 
decreasing to 71.5±17.6 mm post intervention. There was an unclear trivial effect on 304 
the change in skinfolds from pre to post between FO and P (SMD: 0.02 trivial; 1/95/3 305 
unclear). 306 
 307 
Countermovement Jump 308 
Peak force during the CMJ at baseline was 2705.2±271.4 N (range 2399.8–3031.8 N) 309 
and 2858.5±339.7 N (range 2269.4–3183.7 N) for FO and P groups, respectively. By 310 
day 35 of the training camp, 7 participants in P recorded lower CMJ peak force scores 311 
compared with baseline resulting in a mean decrease of 3.4±8.6% (2772.4±481.1 N). 312 
In contrast, peak force during the CMJ increased by 4.6±5.9% by day 35 in FO 313 
(2816.0±309.0 N), with only two participants producing less force on day 35 314 
compared to baseline. Expressed as change in CMJ peak force from baseline, there 315 
was a likely beneficial effect of FO on CMJ performance at day 16 and day 35 (figure 316 
2).  317 
 318 
Muscle soreness 319 
Expressed as a change from baseline, with the exception of day 12, a likely or very 320 
likely beneficial effect of FO on lower body muscle soreness was observed at all 321 
timepoints (figure 3b). At baseline, median (IQR) upper body muscle soreness was 322 
8(1.5) and 8(2) (maximum value 10 which equates to “no soreness”) for FO and P 323 
  
respectively. On Day 22 (two days after the in -house match), expressed as change 324 
from baseline, there was a likely harmful effect of FO on upper body muscle soreness 325 
whereby the muscle soreness was 4.57 out of a potential score of 10 (no muscle 326 
soreness) for FO and 6.82 for P (Figure 3a). Interestingly, the two players in FO that 327 
recorded the maximum soreness at this time point were forwards and one player 328 
played for the developmental squad against the senior squad for the match, so may 329 
have been subjected to heavier impacts throughout the match. Repeating statistical 330 
analysis of the upper body muscle soreness data set with this player’s data at the 22 331 
day timepoint removed reduced the SMD to -0.84 moderate (7/11/82 unclear).  332 
 333 
Subjective measures of fatigue, sleep, stress and mood 334 
Expressed as a change from baseline, a likely moderate beneficial effect (less fatigue) 335 
of FO was observed for subjective fatigue from Day 20-35 (figure 4), with the mean 336 
decrease for P being greater than 1 (on a 5 point likert scale) on all days compared to 337 
a mean score decrease of less than 1 for FO between days 20-35. However, there was 338 
only trivial or small unclear effects on stress or mood responses (data not shown).  On 339 
Day 22, there was a moderate (0.83) likely beneficial (88/9/3) effect of FO compared 340 
to P on sleep quality, however at all other timepoints there were trivial or small 341 
unclear effects (data not shown).    342 
 343 
Discussion  344 
This is the first study, to our knowledge, to investigate the impact of fish oil derived 345 
omega-3 PUFA ingestion on muscle recovery within the real world, applied, field 346 
setting of elite Rugby Union. We report a very large likely beneficial effect of FO on 347 
increasing blood omega-3 PUFA concentrations compared to P over the course of the 348 
  
pre-season training period. Consistent with our working hypothesis, we observed a 349 
moderate beneficial effect of adding 1546 mg of omega-3 PUFA (551 mg of EPA and 350 
551 mg DHA) to a protein-based drink over 5 weeks of pre-season training on lower 351 
body muscle soreness, fatigue and CMJ performance in professional Rugby Union 352 
players competing in the Super Rugby competition. In contrast, there was a trivial 353 
effect of adding omega-3 PUFA to a protein-based drink on sleep, stress and mood. 354 
These data suggest that twice per day supplementation with a protein-based drink 355 
containing omega-3 PUFA has the potential to attenuate lower body muscle soreness 356 
and fatigue and better maintain neuromuscular performance in elite Rugby Union 357 
players during pre-season training. The present study findings could have important 358 
implications for Rugby Union players in terms of minimizing muscle soreness and 359 
fatigue and maintaining performance when the recovery period between training 360 
sessions or match-play is short. In the current study the time between the match and 361 
the physiological measurements was similar to the time period between matches and 362 
training typically scheduled during the competitive season. In theory, reducing the 363 
severity of muscle soreness between matches and training could have beneficial 364 
effects on training performance by allowing players to train at higher intensities 365 
during the season. Furthermore, the reduced muscle soreness with fish oil ingestion 366 
could have a psychological impact by reducing feelings of fatigue, thus improving a 367 
player’s approach to training and matches.  368 
 369 
Several previous studies, conducted in controlled laboratory settings, report a 370 
beneficial effect of fish oil supplementation on the perception of muscle soreness 371 
following intense eccentric exercise (Corder et al., 2016; Tsuchiya et al., 2016; Jouris 372 
et al., 2011; Lembke et al., 2014; Tinsley et al., 2016). Consistent with these 373 
  
experimental study findings, the present field-based study, which included a training 374 
protocol reflective of professional rugby with progressive resistance training and high 375 
volumes of anaerobic training, revealed a moderately beneficial effect of fish oil 376 
ingestion on muscle soreness during preseason Rugby training. Specifically, a 377 
moderate beneficial effect of fish oil ingestion was observed on lower limb muscle 378 
soreness, whereas the effect on upper body soreness was unclear. We speculate that 379 
the beneficial effect of fish oil ingestion was mediated, at least in part, by the 380 
modification of the 3-series eicosanoids, 3-series prostaglandins and 5-series 381 
leukotriene. The 3-series eicosanoids exhibit lower inflammatory properties than the 382 
2-series eicosanoids (PGE2, 4-series leukotriene) and are proposed to decrease the 383 
inflammatory response to exercise and attenuate muscle soreness (Lenn et al., 2002). 384 
In support of this theory, muscle soreness is proposed to be associated with 385 
biochemical muscle damage to the sarcomere and free radical damage (Lewis et al., 386 
2012). This damage leads to an inflammatory response which may contribute to the 387 
sensation of soreness and potentially a decrement in performance (Jakeman, 388 
Lambrick, Wooley, Babraj, & Faulkner, 2017). Alternatively, adding fish oil to a 389 
protein-based drink may attenuate muscle soreness by protecting the structural 390 
integrity of the muscle cell from damage. We previously demonstrated that the 391 
increase in plasma creatine kinase concentrations following eccentric exercise was 392 
reduced with the addition of fish oil to a protein-based supplement (Philpott, 2018). 393 
These data indicate a reduced leakage of creatine kinase from the muscle cell into 394 
circulation following fish oil ingestion. Hence, the exact mechanism for fish oil 395 
ingestion reducing muscle soreness remains unclear.  396 
 397 
  
The better CMJ performance scores with fish oil ingestion may also be due to a 398 
reduced perception of muscle soreness. Alternatively, the benefit of fish oil ingestion 399 
on CMJ performance may have been mediated at the neuromuscular level since 400 
explosive power is determined by both the stretch-shortening cycle as well as the 401 
contractile properties of the muscle (add ref). Accordingly, previous studies 402 
demonstrate that decrements in CMJ performance in professional Rugby League 403 
players during the initial 48 hours following matchplay are due, in part, to changes in 404 
neural fatigue (McLean et al., 2010). Interestingly, a recent study reported that 21 405 
days of fish oil supplementation exhibited positive changes in neuromuscular function 406 
(Lewis et al., 2015) which could explain the findings in the present study. Due to the 407 
nature of conducting research in an applied field setting with elite athletes, it was not 408 
possible to collect venous blood samples for analysis of blood markers of muscle 409 
damage, inflammation or oxidative stress. Furthermore, it was not possible to conduct 410 
more direct measurements of neuromuscular function such as EMG. Therefore, it was 411 
not possible to definitively explain the mechanisms mediating the link between fish 412 
oil ingestion and better CMJ performance. Future applied research designs are 413 
warranted in the context of fish oil ingestion and recovery to measure performance 414 
outcomes alongside more mechanistic biochemical and neuromuscular measurements.   415 
 416 
The beneficial effects of fish oil ingestion on muscle soreness were observed 36 hours 417 
following international travel. Jet-lag occurs when greater than three time zones have 418 
been crossed (O'Connor & Morgan, 1990). In the present study, players crossed three 419 
time zones between Australia and New Zealand. Symptoms of jet-lag include fatigue, 420 
inability to sleep and potentially decrements in CMJ (Chapman, Bullock, Ross, 421 
Rosemond, & Martin, 2012). On day 35, there were beneficial effects of FO on CMJ, 422 
  
and moderately lower fatigue scores. Hence, we may speculate that FO ingestion 423 
attenuated the detrimental impact of jet-lag on muscle recovery in our cohort of elite 424 
Rugby Union players and thus a follow-up study is warranted.  425 
 426 
Despite the present study revealing a beneficial effect of adding omega-3 fatty acids 427 
to a protein-based supplement on muscle soreness and CMJ performance, we did 428 
detect a detrimental effect on upper body muscle soreness on day 22. This observation 429 
may be due to the preseason training schedule including a match on day 20 where we 430 
were unable to control workload between test drink conditions as previously achieved 431 
with training sessions. Also noteworthy was the observation that the highest upper 432 
body muscle soreness scores were reported by two forwards who are typically 433 
involved in the majority of collision impacts. One player was a flanker and this 434 
position is characterized by frequent involvement in breakdown play and subsequent 435 
impact on the upper body. These physical demands may have impacted the soreness 436 
results at this time point, especially since only trivial or moderately beneficial effects 437 
of FO on upper body soreness were detected at all other timepoints. In the present 438 
study, the primary endpoint measurement of performance was focused on CMJ 439 
performance. Therefore, we cannot discern the impact of fish oil ingestion on upper 440 
body performance in this study. It is possible that the study duration was not sufficient 441 
for maximal incorporation of EPA and DHA into the muscle phospholipid membrane. 442 
This notion is based on the findings of McGlory et al., (2014) that reported an 443 
increase in n-3 polyunsaturated fatty acid muscle lipid composition after 2 weeks of 444 
fish oil supplementation at a dose of 5g/day, with these rates of incorporation 445 
continuing to rise after 4 weeks of supplementation (McGlory et al., 2014). Given the 446 
lower relative dose of fish oil administered in the present study, it may be argued that 447 
  
our supplementation regimen was not optimal. However, based on the work of 448 
McGlory et al (2014), 5 weeks of supplementation was likely sufficient to detect a 449 
significant increase in the level of n-3 PUFA incorporation into muscle in our cohort 450 
of elite Rugby Union players.  451 
 452 
Despite the beneficial effects of adding fish oil to a protein-based supplement on 453 
fatigue, other markers of wellness, stress, mood and sleep quality were only trivially 454 
affected. However, no player reported a score lower than “normal” for stress or mood 455 
and only one player rated sleep as lower than “normal” throughout the study. These 456 
data suggest that although the training camp was intensive, it had little impact on 457 
player mood, stress or sleep quality. Therefore, any potential impact of fish oil 458 
ingestion on these measures could not be detected in this study.  459 
 460 
Conclusion 461 
The addition of fish oil (1546 mg of omega-3 PUFA; 551 mg EPA and 551 mg DHA) 462 
to a protein-based drink for 5 weeks provided an effective strategy to reduce muscle 463 
soreness and fatigue and better maintain CMJ performance during preseason training 464 
in elite Rugby Union players. These beneficial effects may confer benefits to muscle 465 
recovery between training sessions and also improve subsequent matchplay 466 
performance, especially when the period between matches is short.  467 
 468 
 469 
 470 
 471 
 472 
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Table Captions 641 
 642 
Table 1: Study protocol outline 643 
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Figure Captions 646 
Figure 1: Omega-3 Polyunsaturated acid (PUFA) concentrations (%) at baseline, Day 647 
19 and End (Day 35) for Fish Oil and Placebo.  648 
 649 
 650 
Figure 2: Countermovement jump performance, expressed as mean(SD) percent 651 
change from baseline for fish oil (FO) and placebo (P) conditions during the 35 day 652 
period of pre-season training. 653 
 654 
Figure 3: Muscle soreness (A, upper body; B, lower body), expressed as mean(SD) 655 
change from baseline for fish oil (FO) and placebo (P) conditions during the 35 day 656 
pre-season training period. 657 
 658 
Figure 4: Fatigue score, expressed as mean(SD) change from baseline for fish oil 659 
(FO) and placebo (P) conditions during the 35 day period of pre-season training. 660 
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